23andMe rethink their business model and purpose. Stop working on advanced gene sequencing.
Rather than spread itself thin on a wide variety of genetic tests, the company took the more strategic decision to focus on its core existing business. Taking a more pragmatic view, the team at 23andMe has dialed back some of its grandiose plans for DNA analysis. As confirmed by co-founder Anne Wojcicki to BuzzFeed, the company…
